General discussion - Round-table meeting "the therapeutic index of antihistamines" Amsterdam, 5-6 May 1998

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 55, Issue SUPPL. 60, 2000, Pages 62-69

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879769092     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2000.00010.x     Document Type: Short Survey

References (13)

1. SIMONS FER, WATSON WTA, MINUK GY, SIMONS KJ. Cetirizine pharmacokinetics and pharmacodynamics in primary biliary cirrhosis. J Clin Pharmacol 1993;33:949-954.
2. ARNOLD R, KÖNIG B, KÖNIG W. G-proteins in allergy. Clin Exp Allergy 1998;27 Suppl 2:1.
3. 1 receptor blockade on the early and late responseto cutaneous allergen challenge. J Pharmacol Exp Ther 1992;262:964-970.
4. CIPRANDI G, BUSCAGLIA S, PESCE G, et al.Cetirizine reduces inflammatory cell recruitment and ICAM-1 (CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge. J Allergy Clin Immunol 1995;95:612-621.
5. CIPRANDI G, BUSCAGLIA S, PRONZATO C, et al. Oxatomide reduces inflammatoryevents induced by allergen-specific conjunctival challenge. Ann Allergy 1995;75:446-452.
6. CIPRANDI G, BUSCAGLIA S, MARCHESI E, DANZIG M, KUSS F, CANONICA GW. Protective effect of loratadine on late phase reaction induced by conjunctival provocation test. Int Arch Allergy Appl Immunol 1992;907:1-5.
7. CIPRANDI G, BUSCAGLIA S, IUDICE A, CANONICA GW. Protective effect of terfenadine at different dosage on conjunctival provocation test. Allergy 1992;47:309-322.
8. ZWEIMAN B, ATKINS PC, MOSKOVITZ A, vON ALLMEN C, CILIBERTI M, GROSSMAN S. Cellular inflammatory responses during immediate, developing, and established late-phase allergic cutaneous reactions: effects of cetirizine. J Allergy Clin Immunol 1997;100:341-347.
9. ATKINS PC, ZWEIMAN B, MOSKOVITZ A, vON ALLMEN C, CILIBERTI M. Cellular inflammatory responses and mediator release during early developing latephase allergic cutaneous inflammatoryresponses: effects of cetirizine. J Allergy Clin Immunol 1997;99:806-811.
10. CAPRONI M, GIOVANNII MP, FALCOS D. Pharmacologic modulation by cetirizine of some adhesion molecule expression in psoriatic skin lesions. Int J Dermatol 1995;34:510-513.
11. AMSELLEM C,GORMAND F,HOSNI R, et al.Antihistamines and production of granulocyte-macrophage colony stimulating factor and interleukin-8 by human bronchial epithelial cells in vitro: evaluation of the effects of loratadineand cetirizine. Gen Pharmacol 1996;27:269-272.
12. BURTIN B, FAYOL C, MARQUIS P, et al. Cetirizine improves quality of life as assessed by the SF-36 questionnaire (SF-36) in perennial allergic rhinitis [Abstract]. J Allergy Clin Immunol 1994;93:163.
13. BOUSQUET J, DUCHATEAU J, PIGNAT JC, et al. Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire. J Allergy Clin Immunol 1996;98:309-316.